Xueyan Chen

1.2k total citations
56 papers, 656 citations indexed

About

Xueyan Chen is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Xueyan Chen has authored 56 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 15 papers in Public Health, Environmental and Occupational Health and 14 papers in Genetics. Recurrent topics in Xueyan Chen's work include Acute Myeloid Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (14 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Xueyan Chen is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (14 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Xueyan Chen collaborates with scholars based in United States, China and India. Xueyan Chen's co-authors include Brent L. Wood, Sindhu Cherian, Elihu H. Estey, Janis L. Abkowitz, Vicky Sandhu, Roland B. Walter, Frederick R. Appelbaum, Pamela S. Becker, John M. Pagel and Hu Xie and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Xueyan Chen

47 papers receiving 652 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xueyan Chen 314 187 138 126 85 56 656
Sagar Sardesai 108 0.3× 175 0.9× 50 0.4× 66 0.5× 174 2.0× 47 603
Arjan D. Barendrecht 255 0.8× 105 0.6× 19 0.1× 123 1.0× 43 0.5× 31 613
Takuro Nishikawa 118 0.4× 221 1.2× 64 0.5× 47 0.4× 240 2.8× 60 677
Silvia Costantini 195 0.6× 191 1.0× 42 0.3× 287 2.3× 71 0.8× 46 697
Daphne Stewart 133 0.4× 321 1.7× 32 0.2× 27 0.2× 156 1.8× 42 666
Patrick J. Kerzic 342 1.1× 180 1.0× 73 0.5× 123 1.0× 241 2.8× 19 775
Hana Manceau 117 0.4× 557 3.0× 27 0.2× 86 0.7× 56 0.7× 29 932
Alpana Saxena 63 0.2× 402 2.1× 27 0.2× 44 0.3× 112 1.3× 56 663
Ümit Zeybek 44 0.1× 238 1.3× 44 0.3× 21 0.2× 117 1.4× 50 613
Konstantinos Stamoulis 308 1.0× 310 1.7× 19 0.1× 188 1.5× 45 0.5× 36 1.2k

Countries citing papers authored by Xueyan Chen

Since Specialization
Citations

This map shows the geographic impact of Xueyan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueyan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueyan Chen more than expected).

Fields of papers citing papers by Xueyan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueyan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueyan Chen. The network helps show where Xueyan Chen may publish in the future.

Co-authorship network of co-authors of Xueyan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xueyan Chen. A scholar is included among the top collaborators of Xueyan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueyan Chen. Xueyan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Tao, Chuchu Wang, Yanmin Duan, et al.. (2025). Activation of sigma 1 receptor attenuates doxorubicin-induced cardiotoxicity by alleviating oxidative stress, mitochondria dysfunction, ER stress-related apoptosis, and autophagy impairment. International Journal of Biological Macromolecules. 310(Pt 4). 143549–143549. 1 indexed citations
2.
Chen, Xueyan, Nikhil Patkar, Prashant Tembhare, et al.. (2025). Fifth edition WHO classification: myeloid neoplasms. Journal of Clinical Pathology. 78(5). 335–345.
4.
Appelbaum, Jacob, Kathryn Russell, Xueyan Chen, et al.. (2024). Hematopoietic stem cell transplant for adults with mixed phenotypic acute leukemia.. Journal of Clinical Oncology. 42(16_suppl). 6517–6517.
5.
Moore, Margaret E., et al.. (2024). Evaluating pathologist practices in peripheral blood smear review: A comprehensive practice survey. American Journal of Clinical Pathology. 163(1). 42–51. 1 indexed citations
7.
Chen, Xueyan, Qi Gao, Mikhail Roshal, & Sindhu Cherian. (2023). Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy. Cytometry Part B Clinical Cytometry. 104(3). 205–223. 7 indexed citations
8.
Ji, Yuan, Jun Wang, Qi Shen, et al.. (2022). Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literature. Modern Pathology. 35(7). 865–874. 7 indexed citations
9.
Chen, Xueyan, Jonathan R. Fromm, & Kikkeri N. Naresh. (2022). “Blasts” in myeloid neoplasms – how do we define blasts and how do we incorporate them into diagnostic schema moving forward?. Leukemia. 36(2). 327–332. 7 indexed citations
10.
Wang, Anlai, Zhili Song, Gang Zheng, et al.. (2021). Evaluation of Preclinical Activity of Isatuximab in Patients with Acute Lymphoblastic Leukemia. Molecular Cancer Therapeutics. 20(10). 1916–1925. 11 indexed citations
11.
Chen, Xueyan, Yu Liu, Donghui Pan, et al.. (2021). 68Ga-NOTA PET imaging for gastric emptying assessment in mice. BMC Gastroenterology. 21(1). 69–69. 2 indexed citations
12.
Chen, Xueyan & Sindhu Cherian. (2021). Role of Minimal Residual Disease Testing in Acute Myeloid Leukemia. Clinics in Laboratory Medicine. 41(3). 467–483. 3 indexed citations
13.
Chen, Xueyan, et al.. (2020). Rare Case of Diffuse Large B-Cell Lymphoma Mimicking Acute Monocytic Leukemia, Associated with Complex Karyotype.. 50(3). 397–400. 1 indexed citations
14.
Li, Ruimin, et al.. (2020). AML-MRC with Basophilia Mimicking CLPD Due to Abnormally Clumped Chromatin. Indian Journal of Hematology and Blood Transfusion. 36(4). 781–783.
15.
Chen, Xueyan & Brent L. Wood. (2017). How do we measure MRD in ALL and how should measurements affect decisions. Re: Treatment and prognosis?. Best Practice & Research Clinical Haematology. 30(3). 237–248. 25 indexed citations
16.
Chen, Xueyan & Sindhu Cherian. (2017). Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis. Clinics in Laboratory Medicine. 37(4). 753–769. 33 indexed citations
17.
Liang, Yundan, et al.. (2015). Genetic variants in the promoters of let-7 family are associated with an increased risk of major depressive disorder. Journal of Affective Disorders. 183. 295–299. 25 indexed citations
18.
Chen, Xueyan, et al.. (2015). Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis. Experimental Biology and Medicine. 240(12). 1672–1681. 38 indexed citations
19.
Jiang, Yunfa, Xueyan Chen, Tao Ding, et al.. (2015). Comparative Efficacy and Safety of OADs in Management of GDM: Network Meta-analysis of Randomized Controlled Trials. The Journal of Clinical Endocrinology & Metabolism. 100(5). 2071–2080. 65 indexed citations
20.
Sun, Hanwen, Liqing Li, & Xueyan Chen. (2006). Investigation on sensitized chemiluminescence systems and their mechanism for five fluoroquinolones. Analytica Chimica Acta. 576(2). 192–199. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026